Clinical Trials on Central Nervous System Diseases in Australia

Total 9992 results

Pulse Therapeutics

Terminated

A Safety Evaluation of the Use of Magnetic-guided Iron Particles

Ischemic Stroke

Australia
Murdoch Childrens Research Institute

Recruiting

Methylphenidate in Childhood Apraxia of Speech

Childhood Apraxia of Speech

Australia
Impel Pharmaceuticals

Completed

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 (SNAP101)

Acute Agitation

Australia
Medical University of Vienna

Unknown

Application of a TBE-Vaccine in Obese Persons

Tick Borne Encephalitis

Austria
Medical University of Graz
Joanneum Research Forschungsgesellschaft mbH; Sozialverein Deutschlandsberg... and other collaborators

Unknown

Playful Multimodal Intervention, Monitoring and Decision Support for Activation of People With Alzheimer's Dementia (M-AAL)

Alzheimer Disease

Austria
Clene Nanomedicine

Active, not recruiting

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

Amyotrophic Lateral Sclerosis

Australia
Great Ormond Street Hospital for Children NHS Foundation...
The Hospital for Sick Children; Boston Children's Hospital; Murdoch Childrens...

Recruiting

Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services (Gene-STEPS)

Epilepsy

United States, Canada, Australia, United Kingdom
Assistance Publique - Hôpitaux de Paris
National Health and Medical Research Council, Australia; Bristol-Myers Squibb; Sano...

Completed

Aortic Arch Related Cerebral Hazard Trial (ARCH) (ARCH)

Embolism | Transient Ischemic Attack | Brain Infarction

Australia, France
Flinders University
Bayer

Completed

BAY2586116 Nasal Spray and OSA Severity

Sleep Apnea, Obstructive

Australia
Medical University of Vienna
Austrian Science Fund (FWF)

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Tick Borne Encephalitis

Austria
Bayer

Completed

Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration (KOALA)

Sleep Apnea, Obstructive

Australia
Dart NeuroScience, LLC

Terminated

DNS-3379 vs. Placebo in Stroke Rehabilitation (SPIRIT)

Ischemic Stroke

Australia, New Zealand
Medical University of Vienna
Daiichi Sankyo, Inc.

Recruiting

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases (TUXEDO-2)

Breast Cancer Stage IV

Austria
The University of Queensland
University of Alabama at Birmingham; Rush University Medical Center; University...

Completed

Coping Skills Training for Living With Chronic Low Back Pain

Low Back Pain

Australia
University of Calgary

Active, not recruiting

A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion (TEMPO-2)

Stroke, Acute

United Kingdom, Australia, Canada, Singapore, New Zealand, Brazil, Ireland, Spain, Austria, Finland
Kepler University Hospital

Completed

Burr Hole Ultrasound Study

Chronic Subdural Hematoma

Austria
Allergan

Terminated

Safety and Efficacy of AGN201781 in Neuropathic Pain

Neuralgia

Germany, Australia
Forest Laboratories

Completed

Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease

Alzheimer's Disease

Australia, New Zealand, South Africa
The University of Queensland
University of Alabama, Tuscaloosa

Not yet recruiting

Mind-body Therapies for Injury-related Pain Management in Elite Athletes

Pain, Acute

Australia
Bayer

Completed

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Multiple Sclerosis | Positron-Emission Tomography

Australia, Sweden
Royal Perth Hospital
Royal Perth Hospital Medical Research Foundation

Completed

Behavioural Intervention for Dysphagia in Acute Stroke

Dysphagia

Australia
Massachusetts General Hospital
National Institute of Nursing Research (NINR); Dana-Farber Cancer Institute; University... and other collaborators

Recruiting

The PediQUEST Response to Pain Of Children With Neurologic Disability Pilot Randomized Controlled Trial (PQ-ResPOND)

Pain | Disabilities Multiple | Cerebral Palsy Infantile

United States, Australia
Valneva Austria GmbH

Completed

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis

Austria, Germany
Medical University of Vienna

Completed

The Neuromarker S-100B in Patients With Different Types of Intracranial Injury

Trauma | Traumatic Brain Injury

Austria
Melbourne Health
Sanofi

Withdrawn

Complement Activation in the Lysosomal Storage Disorders (CATALYST)

Lysosomal Storage Diseases | Fabry Disease | Niemann-Pick Disease, Type C | Gaucher Disease

Australia
The University of Queensland

Completed

Mindfulness Meditation Versus Clinical Hypnosis for Acute, Experimental Pain

Mindfulness Meditation | Clinical Hypnosis

Australia
Collaborative Medicinal Development Pty Limited

Completed

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
Sensorion

Active, not recruiting

Evaluation of the Presence of SENS-401 in the Perilymph

Hearing Loss

Australia
Sonova AG

Completed

Hearing Aid Transmitter Performance Study - SRF-366

Hearing Loss

Australia
Sheba Medical Center
Maccabi Healthcare Services, Israel

Completed

CCT for Older Diabetic Adults

Diabetes | Older Diabetic Persons Without Dementia

Israel
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Meningitis | Meningococcal Infection

Australia
Moleac Pte Ltd.
Moleac Australia Pty Ltd

Completed

Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects

Stroke

Australia
Medical University of Vienna

Recruiting

Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Austria
University of Calgary
The George Institute for Global Health, Australia

Not yet recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 (ACT-WHEN)

Acute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke Acute

Canada, Australia
Medical University of Vienna

Completed

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Vaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization Treatment

Austria
Axon Neuroscience SE

Completed

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (FUNDAMANT)

Alzheimer's Disease

Austria
Alector Inc.

Completed

First in Human Study for Safety and Tolerability of AL003.

Healthy | Alzheimer Disease

United States, Australia
Janssen-Cilag Pty Ltd

Completed

Prospective Research in Memory Clinics (PRIME)

Dementia | Mild Cognitive Impairment

Australia
Merck Sharp & Dohme LLC

Completed

Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)

Mild Cognitive Impairment | Alzheimer's Disease

United States, Australia
Medical University of Graz

Enrolling by invitation

Tracking General Movements

Cerebral Palsy | Clinical Reasoning | General Movement Assessment

Austria
CSL Limited

Completed

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP)

Australia
Cognition Therapeutics

Completed

Ascending Dose Study of CT1812 in Healthy Volunteers

Cognitive Impairment

Australia
The University of Queensland

Not yet recruiting

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside (ATNAD)

Ataxia Telangiectasia

Australia
Debiopharm International SA

Completed

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease (BRAINz)

Moderate Alzheimer's Disease

Australia, Canada, United Kingdom
University of Melbourne
National Health and Medical Research Council, Australia

Completed

Effectiveness of Physiotherapy for Chronic Shoulder Pain

Shoulder Pain

Australia
Cynata Therapeutics Limited

Active, not recruiting

Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers

Diabetic Foot Ulcer | Cutaneous Ulcer

Australia
Bionomics Limited

Completed

A Study of BNC210 in Elderly Patients With Agitation

Agitation in the Elderly

Australia
Central Coast Local Health District

Unknown

Prospective Randomised Controlled Trial of Delirium Management by Geriatric Medicine Versus General Medicine (CADIS)

Delirium

Australia
Valneva Austria GmbH

Completed

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Japanese Encephalitis

Germany, Austria
Athira Pharma
National Institute on Aging (NIA)

Completed

A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease (ACT-AD)

Alzheimer Disease | Dementia of Alzheimer Type

United States, Australia

Clinical Trials on Central Nervous System Diseases in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations